Kronox Lab Sciences DuPont analysis

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
0.74×0.74×0.74×0.75×
1.17×1.16×1.08×1.06×
31.4%31.8%31.7%30.1%
0.89×0.89×1.16×1.21×
1.10×1.10×1.10×1.12×
26.5%26.7%32.1%32.1%
26.8%26.8%32.4%32.2%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

KRONOX₹194.73

Kronox Lab Sciences Limited

· Chemicals
₹ CrorePeersJAYAGROGNDMCCSRHHYPOLTDCHEMFABPRIMOPLASTIBLENGEMAROMASUDARCOLORMcap ₹723 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.750.740.740.74
Interest Burden (Pretax/EBIT) ×1.061.081.161.17
EBIT Margin %30.0831.6831.8331.42
Asset Turnover ×1.211.160.890.89
Financial Leverage (Assets/Equity) ×1.121.101.101.10
ROE (5-step product, year-end total equity) %32.0832.1426.7126.51
ROE (owners' profit / average owners' equity) %32.2032.3626.8226.82
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.